TrialAnnals of the American Thoracic Society2026

Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in adolescents and adults with cystic fibrosis and F508del-gating and F508del-residual function genotypes: results from an open-label extension study.

James F Chmiel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.